Meeting
2011 Breast Cancer Symposium
Prognosis by breast cancer subtypes in patients treated with adjuvant chemotherapy in a clinical trial.
Authors
A. M. G. Ali
South Egypt Cancer Institute, Assiut University, Egypt; Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
A. M. G. Ali , E. Provenzano , J. Abraham , J. M. Bartlett , C. J. Poole , L. Hiller , J. Dunn , C. Twelves , H. M. Earl , C. Caldas , P. Pharoah
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Poster Discussion A
Track
Detection, Screening, and Imaging,Local/Regional Therapy
Sub Track
Predictive and Prognostic Factors
Clinical Trial Registration Number
(ClinicalTrials.gov number, NCT00003577.)
Citation
J Clin Oncol 29, 2011 (suppl 27; abstr 12)
Abstract #
12
Poster Bd #
A10
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
The prognostic role of progesterone receptor in patients with rapidly proliferating, hormone receptor-positive early breast cancer.
First Author: Sara Bravaccini
Poster
2013 ASCO Annual Meeting
Impact of body mass index (BMI) on the prognosis of women with high-risk early breast cancer (BC) receiving adjuvant chemotherapy (CT).
First Author: Alessandra Gennari
Poster
2018 ASCO Annual Meeting
Persistence of circulating tumor cells in high risk early breast cancer patients five years after adjuvant chemotherapy and late recurrence: Results from the adjuvant SUCCESS A trial.
First Author: Wolfgang Janni
First Author: Begoña Bermejo